FdaApplication
BLA 761025
Identifiers
- fda_app_no: BLA761025
Properties
| Property | Value |
|---|---|
| applicant_name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2015-10-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PRAXBIND | IDARUCIZUMAB | 2.5G/50ML | Injection |
1 product